|
|
Volumn 55, Issue 3, 2006, Pages 517-519
|
|
Etanercept for the treatment of psoriasis in the elderly
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
PLACEBO;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DERMATOLOGY;
DISEASE SEVERITY;
DRUG EFFECT;
FEMALE;
GERIATRICS;
HUMAN;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
MALE;
PHASE 3 CLINICAL TRIAL;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
PSORIASIS;
QUALITY OF LIFE;
RANDOMIZATION;
SCORING SYSTEM;
STATISTICAL SIGNIFICANCE;
AGED;
AGING;
CLINICAL TRIALS, PHASE III;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
MIDDLE AGED;
PSORIASIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 33746923093
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2006.02.010 Document Type: Article |
|
Times cited : (53)
|
|
References (5)
|
